20896 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Tripeptides
Methods, compositions, and kits for detection of aspergillosis
#602MetAP2 inhibitors and methods of treating obesity
#603mTORC1 MODULATION BY AMINO ACIDS AND USES THEREOF
#604Methods and compounds to suppress viral genome release and packaging
#605Treatment of impaired cognitive flexibility with TrkB receptor antagonists
#606Covalent granzyme B inhibitors
#607Proline compounds as Granzyme B inhibitors
#608Supramolecular hydrogel of fMLF-based molecules and use thereof
#609CONTEMPORANEOUS, HETEROGENEOUSLY-ORIENTED, MULTI-TARGETED THERAPEUTIC MODIFICATION AND/OR MODULATION OF DISEASE BY ADMINISTRATION OF SULFUR-CONTAINING, AMINO ACID-SPECIFIC SMALL MOLECULES
#610Methods for preventing and treating oral cancers
#611IAP antagonists
#612Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing
#613Solid Pharmaceutical Compositions for Treating HCV
#614COMPOSITION INVOLVED IN REGULATING ENERGY CYCLE, INFLAMMATION AND INSULIN RESISTANCE DYSFUNCTIONS, AND USE THEREOF PARTICULARLY IN CARDIOMETABOLIC DISEASES
#615Methods and compositions for treating solid tumors and enhancing tumor vaccines
#616Tripeptide epoxy ketone protease inhibitors
#617Methods and compositions for preserving retinal ganglion cells
#618CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#619Conjugates for treating diseases caused by PSMA expressing cells
#620Inhibitors of hepatitis C virus
#621METHODS FOR TREATING HCV
#622Synthesis of syrbactin proteasome inhibitors
#623Dual acting prodrugs
#624METAP2 inhibitors and methods of treating obesity
#625NOVEL DISINTEGRATION SYSTEMS FOR PHARMACEUTICAL DOSAGE FORMS
#626METHODS OF TREATING BRAIN DISORDERS OR IDENTIFYING BIOMARKERS RELATED THERETO
#627PHARMACEUTICAL COMPOSITION OF SELECTIVE HCV NS3/4A INHIBITORS
#628Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
#629HCV PROTEASE INHIBITORS AND USES THEREOF
#630Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
#631Methods for Treating HCV
#632Methods for Treating HCV
#633Method of preventing or treating skin necroptosis disease comprising RIP3-MLKL pathway blocker
#634Compositions comprising lysozyme hydrolysate for use in keratin-containing tissue
#635Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
#636CXCR antagonistic peptides and uses thereof
#637Treatment of left ventricular non-compaction and dilated cardiomyopathy by inhibiting melanocortin receptor four
#638Peptides and combination of peptides for use in immunotherapy against various tumors
#639Peptides and combination of peptides for use in immunotherapy against various tumors
#640Peptides and combination of peptides for use in immunotherapy against various tumors
#641Peptides and combination of peptides for use in immunotherapy against various tumors
#642Peptides and combination of peptides for use in immunotherapy against various tumors
#643Peptides and combination of peptides for use in immunotherapy against various tumors
#644Peptides and combination of peptides for use in immunotherapy against various tumors
#645Peptides and combination of peptides for use in immunotherapy against various tumors
#646Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
#647Storage stable lyophilized tripeptide formulations
#648CALPAIN INHIBITORS FOR IBD AND COLORECTAL CANCER TREATMENT
#649Peptides for skin rejuvenation and methods of using the same
#650Prodrugs of peptide epoxy ketone protease inhibitors
#651COMPOSITIONS AND METHODS FOR PREDICTION AND TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTIONS
#652METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#653Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
#654HCV protease inhibitors and uses thereof
#655HCV PROTEASE INHIBITORS AND USES THEREOF
#656Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer
#657Thieno[2,3-e]indole derivatives as new antitumor agents
#658Compositions and methods for treating granulomatosis with polyangiitis
#659Aminostatin derivatives for the treatment of arthrosis
#660NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#661Methods and compositions for the prevention or treatment of barth syndrome
#662Crystal forms
#663MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB
#664Hydrogels for delivery of therapeutic compounds
#665METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUE
#666Engineered integrin binding peptide compositions
#667Methods and compositions for detecting and diagnosing diseases and conditions
#668METHODS FOR TREATMENT OF MICROCEPHALY ASSOCIATED AUTISM DISORDERS
#669Methods and compositions for the treatment of axonal and neuronal degeneration
#670COMBINATION THERAPY FOR THE TREATMENT OF ISCHEMIA-REPERFUSION INJURY
#671PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#672Systems and methods for delivery of peptides
#673Cosmetic compositions
#674Compositions and methods of treatment of cancers
#675Peptide therapeutics and methods for using same
#676Compounds for the treatment of pathologies associated with aging and degenerative disorders
#677Hydroxy-ethylene derivatives for the treatment of arthrosis
#678ICE-CLEAVED ALPHA-SYNUCLEIN AS A BIOMARKER
#679Compounds
#680MATERIALS FOR POSITIVE CATHEPSIN B MODULATION AND METHODS OF USE FOR TREATING MILD COGNITIVE IMPAIRMENT (MCI), EARLY DEMENTIA, A-SYNUCLEINOPATHY, TRAUMATIC BRAIN INJURY, CARDIOMYOPATHY, EYE DISEASE AND SKIN DAMAGE
#681Detection and treatment of autoimmune disorders
#682Process for preparing stealth nanoparticles
#683Nutritional supplements containing a peptide component and uses thereof
#684Methods and compositions for regulating SRCA2A expression levels in myocardial infarction
#685METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#686Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#687Molecular Targets for Cardiovascular Disease
#688Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
#689Methods of treatment using water-soluble tryptophan-containing peptides obtained by the hydrolysis of hens eggs lysozyme
#690LLP2A-bisphosphonate conjugates for osteoporosis treatment
#691Hepatitis C virus inhibitors
#692Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
#693MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY
#694Methods and compositions for preventing or treating ophthalmic conditions
#695MICROPOROUS ZIRCONIUM SILICATE AND DIURETICS FOR THE REDUCTION OF POTASSIUM AND TREATMENT OF CHRONIC KIDNEY AND/OR CHRONIC HEART DISEASE
#696CONJUGATION OF PHARMACEUTICALLY ACTIVE AGENTS WITH TRANSTHYRETIN LIGANDS THROUGH ADJUSTABLE LINKERS TO INCREASE SERUM HALF-LIFE
#697Methods of treating a neoplastic disease
#698Cytotoxic and anti-mitotic compounds, and methods of using the same
#699Re-trafficking of herg reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes
#700SMALL MOLECULE MODULATORS OF PCSK9 AND METHODS OF USE THEREOF
#701Dipeptide and tripeptide epoxy ketone protease inhibitors
#702Augmenting the immune response by promoting cell death of immune cells
#703METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#704Hydrophilic self-immolative linkers and conjugates thereof
#705Method of Forming Fragment Ligated Inhibitors
#706Treatment of HIV-1 infection and AIDS
#707Peptide-based hydrogel particles and uses thereof
#708Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation
#709Pharmaceutical composition for treatment of eye pain, containing PGE2 synthesis inhibitor
#710Hepatitis C virus inhibitors
#711Compositions and methods to inactivate and/or reduce production of microbial toxins
#712METAP2 inhibitors and methods of treating obesity
#713Anti-ED-A immunoconjugates for inflammatory bowel disease
#714Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug
#715Crystal forms
#716Mixed disulfide conjugates of thienopyridine compounds and uses thereof
#717Hydrophilic self-immolative linkers and conjugates thereof
#718Treatment Of HIV-1 Infection And AIDS
#719NOVEL ANTIMICROBIAL AGENTS
#720IAP antagonists
#721Conformations of divergent peptides with mineral binding affinity
#722METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#723Neuronal pain pathway
#724Dosage form for insertion into the mouth
#725Fragment ligated inhibitors selective for the polo box domain of PLK1
#726PEPTIDE
#727PEPTIDES COMPRISING A SHORT-CHAIN POLYETHYLENE GLYCOL MOIETY
#728Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor
#729Conjugates for treating diseases caused by PSMA expressing cells
#730Peptide analogues with branched amino acid probe(s)
#731Pharmaceutical compositions comprising selective peptide-based agonists of melanocortin 1 receptor
#732NOVEL CHONDRAMIDE DERIVATIVES
#733Functionalized 9-bromo-camptothecin derivatives
#734NOVEL COMPOUND WITH EFFECTS OF THROMBOLYSIS, FREE RADICAL SCAVENGING AND THROMBUS-TARGETING AS WELL AS PREPARATION METHOD AND USE THEREOF
#735Methods for Treating HCV
#736Method for treating HCV
#737Biodegradable microdepot delivery system for topical delivery
#738Peptides having NF-κB inhibitory activity, or composition comprising same
#739Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
#740Methods and systems for monitoring, diagnosing, and treating chronic obstructive pulmonary disease
#741Hepatitis C virus inhibitors
#742IAP antagonists
#743Hydroxystatin derivatives for the treatment of arthrosis
#744TREATMENT OF AUTISM SPECTRUM DISORDERS USING GLYCYL-L-2-METHYLPROLYL-L-GLUMATIC ACID
#745Bifunctional cytotoxic agents
#746Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
#747Dose Adjustment
#748Derivatives of pyridinone as inhibitors for tissue transglutaminase
#749Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors
#750Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid
#751STABILIZED PHARMACEUTICAL FORMULATIONS OF A POTENT HCV INHIBITOR
#752METHODS FOR TREATMENT AND PREVENTION OF TAUOPATHIES BY INHIBITING ENDOTHELIN RECEPTORS
#753HCV protease inhibitors and uses thereof
#754INHIBITORS OF HEPATITIS C VIRUS
#755Viral polymerase inhibitors
#756Peptoids useful for the mineralization of apatite
#757METHODS FOR TREATING LIVER TRANSPLANT RECIPIENTS
#758Linear peptide antibiotics
#759COMBINATION THERAPY FOR TREATING HCV INFECTION IN AN HCV-HIV COINFECTED PATIENT POPULATION
#760IAP antagonists
#761Treatments of oxidative stress conditions
#762Biomarkers of response to proteasome inhibitors
#763Composition and method for an intradermal hair growth solution
#764Macrocyclic modulators of the ghrelin receptor
#765Solid Pharmaceutical Compositions
#766Antiviral compounds
#767Peptide-oligourea chimeric compounds and methods of their use
#768Composition for improving or promoting hair growth containing, as active ingredients, photosensitizer irradiated with light and peptide, and method using same
#769Oral delivery of peptide pharmaceutical compositions
#770NOVEL PROCESS FOR PREPARATION OF ANTIBODY CONJUGATES AND NOVEL ANTIBODY CONJUGATES
#771Hepatitis C virus inhibitors
#772Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
#773ORAL SOLID DOSAGE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE
#774Methods for treating lung infections and inflammation
#775Active mixtures of acylated oligopeptides and troxerutin
#776Nutritional composition containing a peptide component with anti-inflammatory properties and uses thereof
#777Compositions and Methods Comprising Carboxylic Acid-Containing Small Molecules
#778Inflammation inhibiting compounds
#779Short antimicrobial lipopeptides
#780Spiro[2.4]heptanes for treatment of Flaviviridae infections
#781Composition for prophylaxis or treatment of vascular or cardiac valvular calcification comprising dipeptidyl peptidase-4 inhibitor
#782Viral polymerase inhibitors
#783Tyrosine based linkers for the releasable connection of peptides
#784Thieno-indole moieties and methods of treating using the same
#785Cholecystokinin B receptor targeting for imaging and therapy
#786Organogels and emulsions for biological and non-biological applications
#787Solid compositions
#788Methods for treating HCV
#789Folate receptor alpha binding ligands
#790Cosmetic use of an albizia julibrissin extract and corresponding topical composition
#791Site-specific chemoenzymatic protein modifications
#792Agonists of neurotrophin receptors and their use as medicaments
#793Factor XII inhibitors for the treatment of neurological inflammatory disorders
#794Conformations of divergent peptides with mineral binding affinity
#795Inhibitors of hepatitis C virus replication
#796USE OF PEPTIDE EPOXYKETONES FOR METASTASIS SUPPRESSION
#797Combination therapies using cyclosporine and aromatic cationic peptides
#798Cytotoxic peptides and antibody drug conjugates thereof
#799GLUTAMINE ENRICHED NUTRITIONAL COMPOSITION FOR PRETERM INFANTS
#800Organic compounds and their uses
#801Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase
#802Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
#803Self-assembled composite ultrasmall peptide-polymer hydrogels
#804Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
#805METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#806Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
#807Compounds, compositions and methods for the treatment of diseases through inhibiting TGF-β activity
#808COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES
#809Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
#810METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#811Tripeptide KDPT for antiapoptotic treatment
#812METHOD OF REDUCING AND IMPROVING THE APPEARANCE OF SCAR TISSUE
#813Cytotoxic and anti-mitotic compounds, and methods of using the same
#814Proteasome inhibitors as ovoprotective agents to shield the ovary from chemotherapy toxicity
#815Methods related to the treatment of neurodegenerative and inflammatory conditions
#816HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER
#817Peptides for skin rejuvenation and methods of using the same
#818Gene signature for the prediction of NF-kappaB activity
#819HCV NS3 protease inhibitors
#820NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#821METHODS OF USE OF GLUTAMINE SYNTHETASE INHIBITORS
#822Systems and methods for delivery of peptides
#823Chiral oligomeric pentenoate amides as bio-oligomer mimetics
#824Methods for reducing CD36 expression
#825Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments
#826Broad-spectrum antivirals against 3C or 3C-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
#827COMBINATION THERAPY FOR TREATING HCV INFECTION IN AN HCV-HIV COINFECTED PATIENT POPULATION
#828Phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition
#829Aromatic-cationic peptides and methods for using same
#830Diagnosis, prognosis, and treatment of kidney disease
#831Use of plant cell membrane treatment of obesity
#832Use of plant cell membrane treatment of obesity
#833Cyclic tripeptide mimetics as plasmin inhibitors
#834Therapeutic agent for emphysema and COPD
#835Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#836Cancer therapies and methods
#837METHODS AND ASSAYS FOR TREATING SUBJECTS WITH SHANK3 DELETION, MUTATION OR REDUCED EXPRESSION
#838INHIBITION OF CYP3A DRUG METABOLISM
#839Peptide compositions and methods for treating patients
#840Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate
#841Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue
#842Spiro[2.4]heptanes for treatment of flaviviridae infections
#843Spiro[2.4]heptanes for treatment of flaviviridae infections
#844Treatment of hepatitis C virus
#845Composition and method for making oligo-benzamide compounds
#846Hepatitis C virus inhibitors
#847Smac mimetic dimers and trimers useful as anti-cancer agents
#848Enkephalin analogues
#849Active agent prodrugs with heterocyclic linkers
#850Peptide analogues with an excellent moisturizing effect and use thereof
#851Modified release formulations for oprozomib
#852Methods for prevention and treatment of acute renal injury
#853Methods for treating HCV
#854Prodrugs of peptide epoxy ketone protease inhibitors
#855Prodrugs of peptide epoxy ketone protease inhibitors
#856Amphiphilic linear peptidepeptoid and hydrogel comprising the same
#857sGCalphal inhibiting compositions
#858Hepatocyte growth factor mimics as therapeutic agents
#859Anti-microbial peptides and uses of same
#860PGC-1α-modulating peptides
#861Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#862Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
#863Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus
#864HCV NS3 protease inhibitors
#865Methods for treating HCV
#866GRANZYME B INHIBITOR COMPOSITIONS, METHODS AND USES FOR PROMOTING WOUND HEALING
#867Compounds for enzyme inhibition
#868Compounds for enzyme inhibition
#869Nanoparticles containing pH-responsive peptide
#870DRUG SUBSTANCES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREPARING THE SAME
#871Methods and compositions for preventing or treating ophthalmic conditions
#872TFEB PHOSPHORYLATION INHIBITORS AND USES THEREOF
#873Selective cysteine protease inhibitors and uses thereof
#874TFEB variants and uses thereof
#875Macrocyclic compounds and methods for their production
#876Compounds for enzyme inhibition
#877Method for enhancing the growth and fullness of hair
#878Macrocyclic inhibitors of flaviviridae viruses
#879Inhibitors of hepatitis C virus
#880Dimeric Smac Mimetics
#881HYDROGEL COMPOSITIONS
#882Methods and compositions for the treatment of axonal and neuronal degeneration
#883HCV protease inhibitors and uses thereof
#884PHARMACEUTICAL COMPOSITION FOR TREATING HCV INFECTIONS
#885Aminostatin derivatives for the treatment of arthrosis
#886Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same
#887Method for treating disorders of the skin
#888Chemosensory Receptor Ligand-Based Therapies
#889Therapeutic or preventive agent for diabetes
#890PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME
#891SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE
#892Prolinamide derivatives as thrombin inhibitors, preparation method and application thereof
#893THERAPEUTIC AGENT FOR PULMONARY SMALL CELL CARCINOMA
#894ORAL COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUBGENOTYPE POPULATIONS
#895ANTIVIRAL AGENT
#896Peptide
#897Viral polymerase inhibitors
#898ORAL COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUB-POPULATION
#899Combinations of Hepatitis C Virus Inhibitors
#900Composition containing peptide ligand that bonds with CXCR2 for treating infective and inflammatory diseases